The price-to-earnings ratio for Revelation Biosciences Inc (NASDAQ: REVB) is above average at 0.07x, Company’s 36-month beta value is 0.21.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for REVB is 0.40M, and currently, short sellers hold a 8.20% ratio of that floaft. The average trading volume of REVB on April 18, 2024 was 398.71K shares.
REVB) stock’s latest price update
Revelation Biosciences Inc (NASDAQ: REVB)’s stock price has gone rise by 12.57 in comparison to its previous close of 1.91, however, the company has experienced a -6.93% decrease in its stock price over the last five trading days. PennyStocks reported 2022-10-26 that Use these technical indicators for trading penny stocks right now The post Buying Penny Stocks? 3 Technical Indicators to Use appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
REVB’s Market Performance
REVB’s stock has fallen by -6.93% in the past week, with a monthly drop of -10.04% and a quarterly drop of -83.54%. The volatility ratio for the week is 14.64% while the volatility levels for the last 30 days are 9.92% for Revelation Biosciences Inc The simple moving average for the past 20 days is -11.17% for REVB’s stock, with a -85.93% simple moving average for the past 200 days.
REVB Trading at -22.78% from the 50-Day Moving Average
After a stumble in the market that brought REVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.68% of loss for the given period.
Volatility was left at 9.92%, however, over the last 30 days, the volatility rate increased by 14.64%, as shares sank -5.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.81% lower at present.
During the last 5 trading sessions, REVB fell by -6.93%, which changed the moving average for the period of 200-days by -92.38% in comparison to the 20-day moving average, which settled at $2.4100. In addition, Revelation Biosciences Inc saw -85.69% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at REVB starting from TIDMARSH GEORGE F, who sale 27,771 shares at the price of $0.52 back on Dec 08 ’23. After this action, TIDMARSH GEORGE F now owns 0 shares of Revelation Biosciences Inc, valued at $14,438 using the latest closing price.
TIDMARSH GEORGE F, the Director of Revelation Biosciences Inc, sale 10,957 shares at $0.66 during a trade that took place back on Oct 16 ’23, which means that TIDMARSH GEORGE F is holding 42,096 shares at $7,243 based on the most recent closing price.
Stock Fundamentals for REVB
The total capital return value is set at -1.3. Equity return is now at value -3.12, with -1.36 for asset returns.
Currently, EBITDA for the company is -8.63 million with net debt to EBITDA at 0.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.17.
Conclusion
In a nutshell, Revelation Biosciences Inc (REVB) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
